Obesity-associated morbidity

Obesity is an important risk factor for many chronic physical and mental illnesses. The generally accepted view is that being overweight causes similar health problems to obesity, but to a lesser degree.[1]

Obesity-associated morbidity
Obesity has a number of medical complications which negatively impact peoples' quality of life.
SpecialtyEndocrinology(other specialties)
Part of a series on
Human body weight
General concepts
Medical concepts
Measurements
Related conditions
Obesity-associated morbidity
Management of obesity
Social aspects

Cardiological
HeartAttack (Myocardial infarction)

Ischemic heart disease

Obesity is associated with cardiovascular diseases including angina and myocardial infarction.[2][3] A 2002 report concluded that 21% of ischemic heart disease is due to obesity[1] while a 2008 European consensus puts the number at 35%.[4]

Congestive heart failure

Having obesity is associated to about 11% of heart failure cases in men and 14% in women.[5]

High blood pressure

More than 85% of those with hypertension have a BMI greater than 25.[5] The risk of hypertension is 5 times higher in the obese as compared to those of normal weight. A definitive link between obesity and hypertension has been found using animal and clinical studies, which have suggested that there are multiple potential mechanisms for obesity-induced hypertension. These mechanisms include the activation of the sympathetic nervous system as well as the activation of the renin–angiotensin–aldosterone system.[6] The association between hypertension and obesity has been also well described in children.[7]

Abnormal cholesterol levels

Obesity is associated with increased LDL cholesterol (bad cholesterol) and lowered HDL cholesterol (good cholesterol).[5][8]

Deep vein thrombosis and pulmonary embolism

Obesity increases one's risk of venous thromboembolism by 2.3 fold.[9][10]

Dermatological

Obesity is associated with the incidence of stretch marks, acanthosis nigricans, lymphedema, cellulitis, hirsutism, and intertrigo.[11][12]

Endocrine
Gynecomastia in an obese male.

Diabetes mellitus

One of the strongest links between obesity and disease is that with type 2 diabetes. These two conditions are so strongly linked that researchers in the 1970s started calling it "diabesity".[5] Excess weight is behind 64% of cases of diabetes in men and 77% of cases in women.[13]

Gynecomastia

Obesity, according to a 2009 review, can be associated with elevated peripheral conversion of androgens into estrogens in some individuals.[14]


Gastrointestinal

Gastroesophageal reflux disease

Several studies have shown that the frequency and severity of GERD symptoms are higher in those who are obese.[15][16]

Cholelithiasis (gallstones)

According to NIH, obesity causes the amount of cholesterol in bile to rise, in turn the formation of stone can occur [5][17]

Reproductive system (or genital system)

Polycystic ovarian syndrome (PCOS)

Due to its association with insulin resistance, the risk of obesity increases with polycystic ovarian syndrome (PCOS). In the US approximately 60% of patients with PCOS have a BMI greater than 30. It remains uncertain whether PCOS contributes to obesity, or the reverse.[18]

Infertility

Obesity leads to infertility in both men and women. This is primarily due to excess estrogen interfering with normal ovulation in women[5] and altering spermatogenesis in men.[19] It is believed to cause 6% of primary infertility.[5][20] A review in 2013 came to the result that obesity increases the risk of oligospermia and azoospermia in men, with an of odds ratio 1.3.[21] Being morbidly obese increases the odds ratio to 2.0.[21]

Complications of pregnancy

Obesity is related to many complications in pregnancy including: haemorrhage, infection, increased hospital stays for the mother, and increased NICU requirements for the infant.[22] Obese women have more than twice the rate of C-sections compared to women of normal weight.[23] Obese women also have increased risk of preterm births and low birth weight infants.[24]

Birth defects

Those who are obese during pregnancy have a greater risk of have a child with a number of congenital malformations including: neural tube defects such as anencephaly and spina bifida, cardiovascular anomalies, including septal anomalies, cleft lip and palate, anorectal malformation, limb reduction anomalies, and hydrocephaly.[25]

Intrauterine fetal death

Maternal obesity is associated with an increased risk of intrauterine fetal death.[20]

Neurological
MCA Territory Infarct (stroke)

Stroke

Ischemic stroke is increased in both men and women who are obese.[5]

Meralgia paresthetica

Meralgia paresthetica is a neuropathic pain or numbness of the thighs, sometimes associated with obesity.[26]

Migraines

Migraine and obesity are comorbid. The risk of migraine rises 50% by BMI of 30 kg/m2 and 100% by BMI of 35 kg/m2.[27] The causal connection remains unclear.[28]

Carpal tunnel syndrome

The risk of carpal tunnel syndrome rises 7.4% for each 1 kg/m2 increase of body mass index.[29]

Dementia

Those who are obese have a rate of dementia 1.4 times greater than those of normal weight.[30]

Idiopathic intracranial hypertension

Idiopathic intracranial hypertension, or unexplained high pressure in the cranium, is a rare condition that can cause visual impairment, frequent severe headache, and tinnitus. It is most commonly seen in obese women.[31][32]

Multiple sclerosis

Women that are obese at age 18 have a greater than twofold increased risk of MS.[33]

Cancer (or oncological)
Hepatocellular carcinoma 1
Main article: Obesity and cancer

Many cancers occur at increased frequency in those who are overweight or obese. A study from the United Kingdom found that approximately 5% of cancer is due to excess weight.[34] These cancers include: [35]

A high body mass index (BMI) is associated with a higher risk of developing ten common cancers including 41% of uterine cancers and at least 10% of gallbladder, kidney, liver and colon cancers in the UK.[36] For those undergoing surgery for cancer, obesity is also associated with an increased risk of major postoperative complications compared with those of normal weight.[37]

Psychiatric
Risk of suicide decreases with increased body mass index in the United States.[38]

Depression

Obesity has been associated with depression.[5] The relationship is strongest in those who are more severely obese, those who are younger, and in women.[39] Suicide rate however decreases with increased BMI.[38]

Social stigmatization

A 2011 systematic review indicated that obese people draw negative reactions, furthermore people are less willing to help the affected individual in any situation.[40]

Respiratory system

Obstructive sleep apnea

Obesity is a risk factor for obstructive sleep apnea.[5][41]

Obesity hypoventilation syndrome
CPAP machine commonly used in OHS

Obesity hypoventilation syndrome is defined as the combination of obesity, hypoxia during sleep, and hypercapnia during the day, resulting from hypoventilation.[42]

Chronic lung disease

Obesity is associated with a number of chronic lung diseases, including asthma and COPD.[41] It is believed that a systemic pro-inflammatory state induced by some causes of obesity may contribute to airway inflammation, leading to asthma.[43]

Complications during general anaesthesia

Obesity significantly reduces and stiffens the functional lung volume, requiring specific strategies for respiratory management under general anesthesia.[44]

Obesity and asthma

The low grade systemic inflammation of obesity has been show to worsen lung function in asthma and increase the risk of developing an asthma exacerbation.[45]

Rheumatological and orthopedic
Gout

Gout

Compared to men with a BMI of 21–23, men with a BMI of 30–35 have 2.3 times more gout, and men with a BMI of greater than 35 have 3.0 times more gout. Weight loss decreases these risks.[46]

Poor mobility

There is a strong association between obesity and musculoskeletal pain and disability.[47]

Osteoarthritis

Increased rates of arthritis are seen in both weight-bearing and non-weight-bearing joints.[5] Weight loss and exercise act to reduce the risk of osteoarthritis.[48]

Low back pain

Obese individuals are twice to four times more likely to have lower back pain than their normal weight peers.[49]

Traumatic injury

In women, class II obesity (i.e. BMI = 35) is a risk factor for osteoporotic fractures in general, as well as for upper arm fractures.[50]

Urological and nephrological
Urinary system

Urinary incontinence

Urge, stress, and mixed incontinence all occur at higher rates in the obese.[51] The rates are about double that found in the normal weight population.[52] Urinary incontinence improves with weight lost.[53]

Chronic kidney disease

Obesity increases one's risk of chronic kidney disease by three to four times.[54]

Hypogonadism

In men, obesity and metabolic syndrome both increase estrogen and adipokine production. This reduces gonadotropin-releasing hormone, in turn reducing both luteinizing hormone and follicle stimulating hormone. The result is reduction of the testis' production of testosterone and a further increase in adipokine levels. This then feeds back to cause further weight gain.[55]

Erectile dysfunction

Obese men can experience erectile dysfunction, (as well as, in association with diabetes), however weight loss causes an improvement in their sexual functioning.[56][57]

See also

References
  1. "Obesity and overweight". World Health Organization. Retrieved 2016-05-17.
  2. Poirier P, Giles TD, Bray GA, et al. (May 2006). "Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss". Arteriosclerosis, Thrombosis, and Vascular Biology. 26 (5): 968–76. CiteSeerX 10.1.1.508.7066. doi:10.1161/01.ATV.0000216787.85457.f3. PMID 16627822.
  3. Yusuf S, Hawken S, Ounpuu S, et al. (2004). "Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study". The Lancet. 364 (9438): 937–52. doi:10.1016/S0140-6736(04)17018-9. PMID 15364185.
  4. Tsigos C, Hainer V, Basdevant A, et al. (2008). "Management of obesity in adults: European clinical practice guidelines". Obes Facts. 1 (2): 106–16. doi:10.1159/000126822. PMC 6452117. PMID 20054170. as PDF Archived 2015-10-17 at the Wayback Machine
  5. Haslam DW, James WP (October 2005). "Obesity". Lancet. 366 (9492): 1197–209. doi:10.1016/S0140-6736(05)67483-1. PMID 16198769. – via ScienceDirect (Subscription may be required or content may be available in libraries.)
  6. Rahmouni K, Correia ML, Haynes WG, Mark AL (January 2005). "Obesity-associated hypertension: new insights into mechanisms". Hypertension. 45 (1): 9–14. doi:10.1161/01.HYP.0000151325.83008.b4. PMID 15583075.
  7. Chiolero A, Bovet P, Paradis G, Paccaud F (March 2007). "Has blood pressure increased in children in response to the obesity epidemic?". Pediatrics. 119 (3): 544–53. doi:10.1542/peds.2006-2136. PMID 17332208.
  8. Malnick, S. D. H.; Knobler, H. (2006-09-01). "The medical complications of obesity". QJM. 99 (9): 565–579. doi:10.1093/qjmed/hcl085. ISSN 1460-2725. PMID 16916862.
  9. Ageno W, Becattini C, Brighton T, Selby R, Kamphuisen PW (January 2008). "Cardiovascular risk factors and venous thromboembolism: a meta-analysis". Circulation. 117 (1): 93–102. doi:10.1161/CIRCULATIONAHA.107.709204. PMID 18086925.
  10. Darvall KA, Sam RC, Silverman SH, Bradbury AW, Adam DJ (February 2007). "Obesity and thrombosis". Eur J Vasc Endovasc Surg. 33 (2): 223–33. doi:10.1016/j.ejvs.2006.10.006. PMID 17185009.
  11. Yosipovitch G, DeVore A, Dawn A (June 2007). "Obesity and the skin: skin physiology and skin manifestations of obesity". J. Am. Acad. Dermatol. 56 (6): 901–16, quiz 917–20. doi:10.1016/j.jaad.2006.12.004. PMID 17504714.
  12. Hahler B (June 2006). "An overview of dermatological conditions commonly associated with the obese patient". Ostomy Wound Manage. 52 (6): 34–6, 38, 40 passim. PMID 16799182.
  13. Peter G. Kopelman; Ian D. Caterson; Michael J. Stock; William H. Dietz (2005). Clinical obesity in adults and children: In Adults and Children. Blackwell. p. 493. ISBN 978-1-4051-1672-5.
  14. Johnson, Ruth E.; Murad, M. Hassan (2009-11-01). "Gynecomastia: Pathophysiology, Evaluation, and Management". Mayo Clinic Proceedings. 84 (11): 1010–1015. doi:10.4065/84.11.1010. ISSN 0025-6196. PMC 2770912. PMID 19880691.
  15. Anand G, Katz PO (2008). "Gastroesophageal reflux disease and obesity". Rev Gastroenterol Disord. 8 (4): 233–9. PMID 19107097.
  16. Ayazi S, Hagen JA, Chan LS, et al. (August 2009). "Obesity and gastroesophageal reflux: quantifying the association between body mass index, esophageal acid exposure, and lower esophageal sphincter status in a large series of patients with reflux symptoms". J. Gastrointest. Surg. 13 (8): 1440–7. doi:10.1007/s11605-009-0930-7. PMC 2710497. PMID 19475461.
  17. "Gallstones". www.niddk.nih.gov. Retrieved 13 May 2016.
  18. Samer El Hayek; Lynn Bitar; Layal H. Hamdar; Fadi G. Mirza; Georges Daoud (5 April 2016). "Poly Cystic Ovarian Syndrome: An Updated Overview". Frontiers in Physiology. 7: 124. doi:10.3389/fphys.2016.00124. PMC 4820451. PMID 27092084.
  19. Hammoud AO, Gibson M, Peterson CM, Meikle AW, Carrell DT (October 2008). "Impact of male obesity on infertility: a critical review of the current literature". Fertil. Steril. 90 (4): 897–904. doi:10.1016/j.fertnstert.2008.08.026. PMID 18929048.
  20. Arendas K, Qiu Q, Gruslin A (June 2008). "Obesity in pregnancy: pre-conceptional to postpartum consequences". J Obstet Gynaecol Can. 30 (6): 477–88. doi:10.1016/s1701-2163(16)32863-8. PMID 18611299.
  21. Sermondade, N.; Faure, C.; Fezeu, L.; et al. (2012). "BMI in relation to sperm count: An updated systematic review and collaborative meta-analysis". Human Reproduction Update. 19 (3): 221–231. doi:10.1093/humupd/dms050. PMC 3621293. PMID 23242914.
  22. Heslehurst N, Simpson H, Ells LJ, et al. (November 2008). "The impact of maternal BMI status on pregnancy outcomes with immediate short-term obstetric resource implications: a meta-analysis". Obes Rev. 9 (6): 635–83. doi:10.1111/j.1467-789X.2008.00511.x. PMID 18673307. Archived from the original on 2019-04-01. Retrieved 2018-11-07.
  23. Poobalan AS, Aucott LS, Gurung T, Smith WC, Bhattacharya S (January 2009). "Obesity as an independent risk factor for elective and emergency caesarean delivery in nulliparous women--systematic review and meta-analysis of cohort studies". Obes Rev. 10 (1): 28–35. doi:10.1111/j.1467-789X.2008.00537.x. PMID 19021871.
  24. McDonald SD, Han Z, Mulla S, Beyene J (2010). "Overweight and obesity in mothers and risk of preterm birth and low birth weight infants: systematic review and meta-analyses". BMJ. 341: c3428. doi:10.1136/bmj.c3428. PMC 2907482. PMID 20647282.
  25. Stothard KJ, Tennant PW, Bell R, Rankin J (February 2009). "Maternal overweight and obesity and the risk of congenital anomalies: a systematic review and meta-analysis". JAMA. 301 (6): 636–50. doi:10.1001/jama.2009.113. PMID 19211471.
  26. Patijn J, Mekhail N, Hayek S, Lataster A, van Kleef M, Van Zundert J (May–June 2011). "Meralgia Paresthetica". Pain Practice. 11 (3): 302–8. doi:10.1111/j.1533-2500.2011.00458.x. PMID 21435164.
  27. Chai NC, Scher AI, Moghekar A, Bond DS, Peterlin BL (February 2014). "Obesity and headache: part I--a systematic review of the epidemiology of obesity and headache". Headache. 54 (2): 219–34. doi:10.1111/head.12296. PMC 3971380. PMID 24512574.
  28. Peterlin BL, Sacco S, Bernecker C, Scher AI (April 2016). "Adipokines and Migraine: A Systematic Review". Headache. 56 (4): 622–44. doi:10.1111/head.12788. PMC 4836978. PMID 27012149.
  29. Shiri R, Pourmemari MH, Falah-Hassani K, Viikari-Juntura E (December 2015). "The effect of excess body mass on the risk of carpal tunnel syndrome: a meta-analysis of 58 studies". Obesity Reviews. 16 (12): 1094–104. doi:10.1111/obr.12324. PMID 26395787.
  30. Beydoun MA, Beydoun HA, Wang Y (May 2008). "Obesity and central obesity as risk factors for incident dementia and its subtypes: A systematic review and meta-analysis". Obes Rev. 9 (3): 204–18. doi:10.1111/j.1467-789X.2008.00473.x. PMC 4887143. PMID 18331422.
  31. Wall M (March 2008). "Idiopathic intracranial hypertension (pseudotumor cerebri)". Curr Neurol Neurosci Rep. 8 (2): 87–93. doi:10.1007/s11910-008-0015-0. PMID 18460275.
  32. Julayanont P, Karukote A, Ruthirago D, Panikkath D, Panikkath R (19 February 2016). "Idiopathic intracranial hypertension: ongoing clinical challenges and future prospects". Journal of Pain Research. 9: 87–99. doi:10.2147/JPR.S60633. PMC 4767055. PMID 26929666.
  33. Munger KL, Chitnis T, Ascherio A (2009). "Body size and risk of MS in two cohorts of US women". Neurology. 73 (19): 1543–50. doi:10.1212/WNL.0b013e3181c0d6e0. PMC 2777074. PMID 19901245.
  34. Reeves GK, Pirie K, Beral V, Green J, Spencer E, Bull D (2016). "Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study". BMJ. 335 (7630): 1134. doi:10.1136/bmj.39367.495995.AE. PMC 2099519. PMID 17986716.
  35. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ (April 2003). "Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults". N. Engl. J. Med. 348 (17): 1625–38. doi:10.1056/NEJMoa021423. PMID 12711737.
  36. Lyford, Joanna (August 2014). "Rising obesity levels in UK could result in 4,000 extra cancer cases each year". The Pharmaceutical Journal.
  37. STARSurg (2016). "Multicentre prospective cohort study of body mass index and postoperative complications following gastrointestinal surgery". BJS. 103 (9): 1157–1172. doi:10.1002/bjs.10203. PMC 4973675. PMID 27321766.
  38. Mukamal KJ, Rimm EB, Kawachi I, O'Reilly EJ, Calle EE, Miller M (November 2009). "Body Mass Index and Risk of Suicide Among One Million US Adults". Epidemiology. 21 (1): 82–6. doi:10.1097/EDE.0b013e3181c1fa2d. PMID 19907331.
  39. Dixon JB, Dixon ME, O'Brien PE (September 2003). "Depression in association with severe obesity: changes with weight loss". Arch. Intern. Med. 163 (17): 2058–65. doi:10.1001/archinte.163.17.2058. PMID 14504119.
  40. Sikorski, Claudia; Luppa, Melanie; Kaiser, Marie; Glaesmer, Heide; Schomerus, Georg; König, Hans-Helmut; Riedel-Heller, Steffi G (2011-08-23). "The stigma of obesity in the general public and its implications for public health - a systematic review". BMC Public Health. 11: 661. doi:10.1186/1471-2458-11-661. ISSN 1471-2458. PMC 3175190. PMID 21859493.
  41. Poulain M, Doucet M, Major GC, et al. (April 2006). "The effect of obesity on chronic respiratory diseases: pathophysiology and therapeutic strategies". CMAJ. 174 (9): 1293–9. doi:10.1503/cmaj.051299. PMC 1435949. PMID 16636330.
  42. Olson, Amy L.; Zwillich, Clifford (2005-09-01). "The obesity hypoventilation syndrome". The American Journal of Medicine. 118 (9): 948–956. doi:10.1016/j.amjmed.2005.03.042. ISSN 0002-9343. PMID 16164877. – via ScienceDirect (Subscription may be required or content may be available in libraries.)
  43. Sutherland ER (August 2008). "Obesity and asthma". Immunol Allergy Clin North Am. 28 (3): 589–602, ix. doi:10.1016/j.iac.2008.03.003. PMC 2504765. PMID 18572109.
  44. Hodgson LE, Murphy PB, Hart N (May 2015). "Respiratory management of the obese patient undergoing surgery". Journal of Thoracic Disease. 7 (5): 943–52. doi:10.3978/j.issn.2072-1439.2015.03.08. PMC 4454851. PMID 26101653.
  45. Peters, Michael C; McGrath, Kelly Wong; Hawkins, Gregory A; Hastie, Annette T; Levy, Bruce D; Israel, Elliot; Phillips, Brenda R; Mauger, David T; Comhair, Suzy A; Erzurum, Serpil C; Johansson, Mats W; Jarjour, Nizar N; Coverstone, Andrea M; Castro, Mario; Holguin, Fernando; Wenzel, Sally E; Woodruff, Prescott G; Bleecker, Eugene R; Fahy, John V (July 2016). "Plasma interleukin-6 concentrations, metabolic dysfunction, and asthma severity: a cross-sectional analysis of two cohorts". The Lancet Respiratory Medicine. 4 (7): 574–584. doi:10.1016/S2213-2600(16)30048-0. PMC 5007068. PMID 27283230.
  46. Choi HK, Atkinson K, Karlson EW, Curhan G (April 2005). "Obesity, weight change, hypertension, diuretic use, and risk of gout in men: the health professionals follow-up study". Arch. Intern. Med. 165 (7): 742–8. doi:10.1001/archinte.165.7.742. PMID 15824292.
  47. Tukker A, Visscher T, Picavet H (April 2008). "Overweight and health problems of the lower extremities: osteoarthritis, pain and disability". Public Health Nutr. 12 (3): 359–68. doi:10.1017/S1368980008002103. PMID 18426630.
  48. Yu SP, Hunter DJ (August 2015). "Managing osteoarthritis". Australian Prescriber. 38 (4): 115–9. doi:10.18773/austprescr.2015.039. PMC 4653978. PMID 26648637.
  49. Molenaar EA, Numans ME, van Ameijden EJ, Grobbee DE (November 2008). "[Considerable comorbidity in overweight adults: results from the Utrecht Health Project]". Ned Tijdschr Geneeskd (in Dutch). 152 (45): 2457–63. PMID 19051798.
  50. Johansson, Helena; Kanis, John A; Odén, Anders; McCloskey, Eugene; Chapurlat, Roland D; Christiansen, Claus; Cummings, Steve R; Diez-Perez, Adolfo; Eisman, John A; Fujiwara, Saeko; Glüer, Claus-C; Goltzman, David; Hans, Didier; Khaw, Kay-Tee; Krieg, Marc-Antoine; Kröger, Heikki; LaCroix, Andrea Z; Lau, Edith; Leslie, William D; Mellström, Dan; Melton, L Joseph; O'Neill, Terence W; Pasco, Julie A; Prior, Jerilynn C; Reid, David M; Rivadeneira, Fernando; van Staa, Tjerd; Yoshimura, Noriko; Zillikens, M Carola (January 2014). "A Meta-Analysis of the Association of Fracture Risk and Body Mass Index in Women". Journal of Bone and Mineral Research. 29 (1): 223–233. doi:10.1002/jbmr.2017. PMID 23775829.
  51. Hunskaar S (2008). "A systematic review of overweight and obesity as risk factors and targets for clinical intervention for urinary incontinence in women". Neurourol. Urodyn. 27 (8): 749–57. doi:10.1002/nau.20635. PMID 18951445.
  52. Bart S, Ciangura C, Thibault F, et al. (September 2008). "[Stress urinary incontinence and obesity]". Prog. Urol. (in French). 18 (8): 493–8. doi:10.1016/j.purol.2008.04.015. PMID 18760738.
  53. Subak LL, Wing R, West DS, et al. (January 2009). "Weight loss to treat urinary incontinence in overweight and obese women". N. Engl. J. Med. 360 (5): 481–90. doi:10.1056/NEJMoa0806375. PMC 2877497. PMID 19179316.
  54. Ejerblad E, Fored CM, Lindblad P, Fryzek J, McLaughlin JK, Nyrén O (2006). "Obesity and risk for chronic renal failure". J. Am. Soc. Nephrol. 17 (6): 1695–702. doi:10.1681/ASN.2005060638. PMID 16641153.
  55. Corona G, Bianchini S, Sforza A, Vignozzi L, Maggi M (October 2015). "Hypogonadism as a possible link between metabolic diseases and erectile dysfunction in aging men". Hormones (Athens). 14 (4): 569–78. doi:10.14310/horm.2002.1635. PMID 26732155.
  56. Corona, Giovanni; Rastrelli, Giulia; Filippi, Sandra; Vignozzi, Linda; Mannucci, Edoardo; Maggi, Mario (2014-01-01). "Erectile dysfunction and central obesity: an Italian perspective". Asian Journal of Andrology. 16 (4): 581–591. doi:10.4103/1008-682X.126386. ISSN 1008-682X. PMC 4104087. PMID 24713832.
  57. Chitaley, Kanchan; Kupelian, Varant; Subak, Leslee; Wessells, Hunter (2009-12-01). "Diabetes, Obesity and Erectile Dysfunction: Field Overview and Research Priorities". The Journal of Urology. 182 (6 Suppl): S45–S50. doi:10.1016/j.juro.2009.07.089. ISSN 0022-5347. PMC 2864637. PMID 19846136.

Further reading
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.